INVESTORS & MEDIA

Press Releases

Press Releases

Precision BioSciences Appoints Dario Scimeca as General Counsel
June 12, 2019
DURHAM, N.C., June 12, 2019 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL), a genome editing company dedicated to improving life through the application of its proprietary ARCUS ® genome editing platform, announced today that Dario Scimeca has joined Precision BioSciences as General...
Precision BioSciences to Present at Upcoming Investor Conferences
May 29, 2019
DURHAM, N.C., May 29, 2019 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL), a genome editing company dedicated to improving life through the application of its proprietary ARCUS ® genome editing platform, today announced that members of its management team will participate in three...
Precision BioSciences Reports First Quarter 2019 Financial Results
April 29, 2019
DURHAM, N.C., April 29, 2019 (GLOBE NEWSWIRE) -- Precision BioSciences, a genome editing company dedicated to improving life (Nasdaq: DTIL) (“Precision”) through the application of its proprietary ARCUS genome editing platform, announced today financial and corporate results for the first quarter...
Precision BioSciences Announces Pricing of Initial Public Offering
March 27, 2019
DURHAM, N.C. , March 27, 2019 (GLOBE NEWSWIRE) -- Precision BioSciences (Nasdaq: DTIL) (“Precision”), a genome editing company dedicated to improving life (DTIL) through its proprietary ARCUS genome editing platform, today announced the pricing of its initial public offering of 7,900,000 shares of...
Raymond Schinazi Joins Precision BioSciences Board of Directors
March 14, 2019
DURHAM, North Carolina, USA, March 14, 2019  – Precision BioSciences (“Precision”), a genome editing company dedicated to improving life (DTIL) through its proprietary ARCUS genome editing platform, has appointed Raymond Schinazi, PhD, Hon DSc to its board of directors. Dr....
Displaying 1 - 10 of 13

INVESTORS & MEDIA

Investor Tools